Abstract
CD27 signaling can either improve T-cell function or lead to T-cell dysfunction, depending on the duration and conditions of receptor ligation. Recent studies have shown that modulating the CD70-CD27 interaction is an attractive strategy to treat solid tumors and also to directly target leukemia stem cells. © 2012 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
APA
Riether, C., Schürch, C., & Ochsenbein, A. F. (2012). Modulating CD27 signaling to treat cancer. OncoImmunology. https://doi.org/10.4161/onci.21425
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free